probenecid has been researched along with iloprost in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (33.33) | 29.6817 |
2010's | 2 (66.67) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Lombardo, F; Obach, RS; Waters, NJ | 1 |
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
Adderley, SP; Bowles, EA; Egan, TM; Ellsworth, ML; Sprague, RS; Sridharan, M; Stephenson, AH | 1 |
3 other study(ies) available for probenecid and iloprost
Article | Year |
---|---|
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Pannexin 1 is the conduit for low oxygen tension-induced ATP release from human erythrocytes.
Topics: Adenosine Triphosphate; Adult; Carbenoxolone; Connexins; Cystic Fibrosis Transmembrane Conductance Regulator; Epoprostenol; Erythrocytes; Female; Glyburide; Humans; Iloprost; Male; Middle Aged; Nerve Tissue Proteins; Oxygen; Probenecid; Receptors, Epoprostenol; Receptors, Prostaglandin | 2010 |